INTRODUCTION
Hepatitis C virus (HCV) is a major cause of acute and chronic liver disease. HCV infection frequently leads to chronic hepatitis aggravated by hepatic fibrosis and steatosis subsequently leads to increase the risk of hepatic cirrhosis and hepatocellular carcinoma that are responsible for high morbidity and mortality rate [1] . In Egypt, HCV infection is a major health problem. According to World Health Organization (WHO), the estimated prevalence is about 22% [2] , because of the very high prevalence rate of HCV in the general Egyptian population, it accounts for most chronic liver diseases and HCC cases in Egypt [3] .
Trace metals are integral part of metalloenzymes and participate in biological functions, such as oxygen transport, free radical scavenging, structural organization of macromolecules, and hormonal activity [3] . Zinc (Zn) is the second most prevalent trace element in the body. It is integrally involved in the normal life cycle and it has many important regulatory, catalytic, and defensive functions [4] . Acute and chronic viral hepatitis are associated with reduced serum zinc levels, without any difference among groups classified according to the etiology or the clinical course of liver disease and the linkage between zinc homeostasis and viral infection could be identified with the assumption that viruses produce severe oxidative stress in the hepatocytes, leading to apoptosis or hepatocytic necrosis and causing a decrease in protein synthesis [6]. The low serum zinc level is common in patients with liver cirrhosis (due to decreased intake, decreased absorption, decreased bioavailability, and increased losses (because of malabsorption) [5] , HCC and in HCC tumor tissue [7] . The decrease in intracellular zinc levels in HCC could be explained by a down regulation of ZIP14 gene expression and the near absence of the protein within hepatoma cells in core biopsy samples. ZIP14 localizes to the cell membrane of normal hepatocytes and is a functional transmembrane transporter involved in the uptake of zinc into the cell [8] . In this study, we evaluated serum zinc levels in patients with HCV induced chronic hepatitis, Liver cirrhosis, and HCC and studied the relationship between these levels and clinical profiles, histopathological criteria and HCC characters of the studied cases.
SUBJECTS AND METHODS
This cross-sectional study was conducted on 69 adult patients with HCV-related chronic liver diseases who were referred to Hepatology, Gastroenterology and Infectious diseases department, Benha University Hospital during the period from August 2013 to April 2014. Twenty three healthy, age and sex matched subjects were selected as controls. An informed medical consents was taken for their participation in the study. The protocol of the study was approved by the human ethical committee of Benha University Hospital. Patients with diseases affecting serum zinc levels such as renal impairment and chronic heart failure, alcohol abuse, diabetes mellitus, previous antiviral treatment, concurrent infections or malignancy other than HCC, chronic HBV infection or concomitant chronic HBV and HCV infections, zinc therapy or using hormonal drugs was excluded in addition to patients subjected to surgery or chemotherapy.
The Studied subjects were stratified into : Group 1 (chronic hepatitis group) that included 23 patients who were diagnosed by liver biopsy. Group2 (cirrhotic group) that included 23 patients in whom cirrhosis was diagnosed by clinical, laboratory data and ultrasonographic examination. Group 3 (HCC group) that included 23 patients with HCV related HCC who were diagnosed by abdominal ultrasonography, triphasic C.T and AFP. Group 4 (control group) that included 23 healthy persons as a control group with no clinical, laboratory or ultrasonographic evidence of illness.
All subjects underwent CBC, liver profile (ALT, AST, and bilirubin using Beckman Synchron CX7 Delta Clinical System, prothrombin time, and INR using stago analyzer), Serum creatinine, Viral markers including : HCV-Ab by Enzyme linked immunosorbent assay (ELISA) (IU/ml) in addition to HBsAg by ELISA (IU/ml), and AFP. Abdominal ultrasonography, abdominal triphasic spiral C.T Scan was done for HCC group. The severity of liver cirrhosis was assessed by ChildPugh score and Barcelona Clinic Liver Cancer (BCLC) staging system was done for HCC group.
Sample preparation: Blood samples were collected under aseptic conditions, then samples protected in evacuated tubes without adding any anticoagulant agent. The samples were left standing for one hour; sera were separated at 3000 rpm centrifugation for 10 min and preserved at -20°C till further analysis.
Method of serum Zn assay:
The sera were diluted 1: 5 with double deionised water. Zn levels were detected by atomic absorption spectrophotometer instrument )Variant Australia) using internal standard )Merck Germany), then the results were multiplied by 5. Normal range of serum Zn is (0.8 -1.5 µg/ml).
Statistical analysis:
Sample size calculation: Sample size was 92 subjects (69 cases and 23 controls). The α level was 0.05 as it represents the type I error probability for a two sided test. The sample size was calculated at 95% confidence level (CL) and power of the study 80%. Z value was 1.96 at 95% CL.
The collected data were tabulated and analyzed using SPSS version 16 software (Spss Inc, Chicago, ILL Company). Statistical analysis was done according to Knapp and Miller [9] .
Categorical data were presented as number and percentages while quantitative data were expressed as mean and standard deviation, median range. Chi square test (X 2 ), Fisher's, ANOVA (F test), student "t", Man Whitney U test, Krauskal Wallis test and Spearman's correlation coefficient (rho) were used as tests of significance.
RESULTS
Patients of HCC group were significantly older than those of chronic hepatitis and cirrhotic groups (P<0.001). There was no statistically significant difference between the studied groups regarding gender. Serum zinc levels were significantly lower in chronic hepatitis group than control group and HCC group (P<0.001). Patients with Child class (C) had lower serum Zn levels than those with Child class (A) with significant difference between them (P= 0.023). Out of 23 Significant positive correlation was found between serum Zn levels and age in cirrhotic group but there was no significant correlation between serum Zn levels and any of laboratory parameters of the studied groups on one hand and fibrosis stages of chronic hepatitis group on the other hand. Negative non significant correlation was detected between serum Zn levels and tumor multiplicity and BCLC in HCC group. 
DISCUSSION
Hepatitis C virus infection is one of the main causes of chronic liver disease worldwide in addition the long-term impact of its infection is highly variable, from minimal changes to extensive fibrosis and cirrhosis with or without hepatocellular carcinoma [10] . In the present study, patients of HCC group were significantly older than those of chronic hepatitis and cirrhotic groups (p<0.001). This result was similar to that found by Wang et al.
[11] and El-Zayadi et al. [12] ; where the latter reported that HCC in Egypt is significantly more prevalent among older age groups than younger age groups and suggested that HCV infection in old patients induces a rapid progression to HCC independent of HCV genotype. Old age is a risk factor for HCC, especially in areas where HCV infection is endemic as Egypt 
